+

NO20070065L - Indolyalkylaminmetabolitter som 5-hydroksytrytamin-6 ligander - Google Patents

Indolyalkylaminmetabolitter som 5-hydroksytrytamin-6 ligander

Info

Publication number
NO20070065L
NO20070065L NO20070065A NO20070065A NO20070065L NO 20070065 L NO20070065 L NO 20070065L NO 20070065 A NO20070065 A NO 20070065A NO 20070065 A NO20070065 A NO 20070065A NO 20070065 L NO20070065 L NO 20070065L
Authority
NO
Norway
Prior art keywords
indolyalkylamine
hydroxytrythamine
metabolites
ligands
receptor
Prior art date
Application number
NO20070065A
Other languages
English (en)
Norwegian (no)
Inventor
Ronald Charles Bernotas
Chia-Cheng Shaw
Youchu Wang
Ping Cai
Chung-Chie Paul Wang
Zhi Wang
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35033547&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20070065(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20070065L publication Critical patent/NO20070065L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals
    • C07H7/033—Uronic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20070065A 2004-06-23 2007-01-04 Indolyalkylaminmetabolitter som 5-hydroksytrytamin-6 ligander NO20070065L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58229004P 2004-06-23 2004-06-23
PCT/US2005/021852 WO2006002125A1 (fr) 2004-06-23 2005-06-21 Metabolites d'indolylalkylamine en tant que ligands de 5-hydroxytrytamine-6

Publications (1)

Publication Number Publication Date
NO20070065L true NO20070065L (no) 2007-01-04

Family

ID=35033547

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070065A NO20070065L (no) 2004-06-23 2007-01-04 Indolyalkylaminmetabolitter som 5-hydroksytrytamin-6 ligander

Country Status (19)

Country Link
US (1) US7498327B2 (fr)
EP (1) EP1758898A1 (fr)
JP (1) JP2008504267A (fr)
KR (1) KR20070041514A (fr)
CN (1) CN1976928A (fr)
AR (1) AR049449A1 (fr)
AU (1) AU2005258025A1 (fr)
BR (1) BRPI0512540A (fr)
CA (1) CA2570818A1 (fr)
CR (1) CR8825A (fr)
EC (1) ECSP067096A (fr)
IL (1) IL180198A0 (fr)
MX (1) MX2007000182A (fr)
NO (1) NO20070065L (fr)
PA (1) PA8637801A1 (fr)
PE (1) PE20060303A1 (fr)
RU (1) RU2006146923A (fr)
TW (1) TW200606148A (fr)
WO (1) WO2006002125A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9101613B2 (en) 2006-02-15 2015-08-11 Neurim Pharmaceuticals (1991) Ltd. Methods for treating neurological disease
US7635710B2 (en) 2006-02-15 2009-12-22 Neurim Pharmaceuticals (1991) Ltd. Pyrone-indole derivatives and process for their preparation
EP1953153A1 (fr) * 2007-01-31 2008-08-06 Laboratorios del Dr. Esteve S.A. Sulfamides substitués d'hétérocyclyle pour le traitement des maladies cognitives ou d'ingestion de la nourriture
EP2053052A1 (fr) 2007-10-23 2009-04-29 Laboratorios del Dr. Esteve S.A. Procédé pour la préparation d'halogénure d'imidazo[2,1-b]thiazole-5-sulfonyle substitué en position 6
US9663498B2 (en) 2013-12-20 2017-05-30 Sunshine Lake Pharma Co., Ltd. Aromatic heterocyclic compounds and their application in pharmaceuticals

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489767A (en) * 1966-01-12 1970-01-13 Sumitomo Chemical Co 1-(phenylsulfonyl)-3-indolyl aliphatic acid derivatives
GB9820113D0 (en) * 1998-09-15 1998-11-11 Merck Sharp & Dohme Therapeutic agents
US6380166B1 (en) * 1999-09-13 2002-04-30 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
CN1309385C (zh) * 2001-12-20 2007-04-11 惠氏公司 作为5－羟色胺－6配体的吲哚基烷基胺衍生物
EP1600440A1 (fr) * 2003-03-06 2005-11-30 Ono Pharmaceutical Co., Ltd. Composes a base de derives d'indole et medicaments contenant lesdits composes en tant que principe actif
US7202266B2 (en) * 2003-07-17 2007-04-10 Plexxikon, Inc. PPAR active compounds
WO2005040112A1 (fr) * 2003-10-14 2005-05-06 Oxagen Limited Composes a activite antagoniste de pgd2

Also Published As

Publication number Publication date
US7498327B2 (en) 2009-03-03
AR049449A1 (es) 2006-08-02
US20060003945A1 (en) 2006-01-05
RU2006146923A (ru) 2008-07-27
BRPI0512540A (pt) 2008-03-25
JP2008504267A (ja) 2008-02-14
CA2570818A1 (fr) 2006-01-05
PA8637801A1 (es) 2006-06-02
PE20060303A1 (es) 2006-05-19
AU2005258025A1 (en) 2006-01-05
TW200606148A (en) 2006-02-16
IL180198A0 (en) 2007-06-03
KR20070041514A (ko) 2007-04-18
CN1976928A (zh) 2007-06-06
CR8825A (es) 2007-08-28
EP1758898A1 (fr) 2007-03-07
ECSP067096A (es) 2007-02-28
MX2007000182A (es) 2007-03-23
WO2006002125A1 (fr) 2006-01-05

Similar Documents

Publication Publication Date Title
NO20050007L (no) 1-Heterosyklylalkyl-3-sulfonylazaindol eller -azaindazolderivater som 5-hydroksytryptamin-6 ligander
NO20050014L (no) 1-Heterosyklylalkyl-3-sulfonylindol eller -indazolderivater som 5-hydroksytryptamin-6 ligander
NO20044763L (no) 1-(aminoalkyl)-3-sulfonylazaindoler som 5-hydroksytryptamin-6 ligander
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20065678L (no) 3-(4-heteroarylcykloheksylamino) cyklopentankarboksamider som modulatorer for kjemokinreseptorer.
NO20053792L (no) Heterocykly-3-sulfonylindazoler som 5-hydroksytryptamin-6 ligander
NO20082285L (no) 3-aminosyklopentankarboksamider som modulatorer av kjemokinreseptorer
NO20070489L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
NO20082096L (no) Azaindol-2-karboksamidderivativer
NO20065984L (no) Forbindelser og sammensetninger som PPAR modulatorer
NO20070487L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
NO20075624L (no) Nye histamin H3-reseptorligander og deres terapeutiske anvendelser
NO20065868L (no) Substituerte aryl- og heteroarylderivater som metabolisme- og profylkasemodulatorer og behandling av forstyrrelser forbundet med dette
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
NO20070855L (no) Arylidener for behandling av estrogenrelaterte reseptor-alfamedierte sykdommer.
NO20072461L (no) Fremstilling og anvendelse av bifenyl-4-yl-karbonylaminosyre derivater for behandling av fedme
NO20090295L (no) Substituerte heteroarylderivater
NO20065983L (no) Forbindelser og sammensetninger som PPAR modulatorer
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
NO20084489L (no) Azolopyrimidiner som inhibitorer av cannabinoid 1 aktivitet
NO20044764L (no) 1-(aminoalkyl)-3-sulfonylindol og -indazolderivater som 5-hydroksytryptamin-6 ligander
NO20083058L (no) Cykloheksylsulfonamidderivater med H3 reseptor aktivitet
NO20074002L (no) Androgen reseptor-modulatorforbindelser og fremgangsmater
NO20032841L (no) Heterocykloindol- eller azaindol-forbindelser som 5- hydroksytryptamin-6-ligander

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载